{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T22:05:44Z","timestamp":1789250744077,"version":"build-2803163510"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2011]]},"DOI":"10.1007\/s10156-010-0192-z","type":"journal-article","created":{"date-parts":[[2010,12,20]],"date-time":"2010-12-20T03:25:54Z","timestamp":1292815554000},"page":"392-396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Clinical efficacy of levofloxacin 500\u00a0mg once daily for 7\u00a0days for patients with non-gonococcal urethritis"],"prefix":"10.1016","volume":"17","author":[{"given":"Satoshi","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohji","family":"Ichihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Kurimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiji","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Iwasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Sunaoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobukazu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s10156-010-0192-z_bib0005","first-page":"35","article-title":"Sexually transmitted diseases treatment guidelines","volume":"55","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1007\/s10156-010-0192-z_bib0010","unstructured":"Grabe M, Bishop MC, Bjerklund-Johansen TE, Botto H, \u00c7ek M, Lobel B, et al. (2009) Urethritis. Guideline on urological infections. In: European Association of Urology Guidelines 2009 edition. European Association of Urology, Arnhem, pp 72\u201373."},{"key":"10.1007\/s10156-010-0192-z_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-010-0192-z_bib0020","first-page":"67","article-title":"Clinical study on ofloxacin and doxycycline in the treatment of male urethritis caused by Chlamydia trachomatis (in Japanese)","volume":"1","author":"Kumamoto","year":"1990","journal-title":"Jpn J Sex Transm Dis"},{"key":"10.1007\/s10156-010-0192-z_bib0025","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00007435-198810000-00002","article-title":"A prospective randomized trial of ofloxacin vs. doxycycline in the treatment of uncomplicated male urethritis","volume":"15","author":"Boslego","year":"1988","journal-title":"Sex Transm Dis"},{"key":"10.1007\/s10156-010-0192-z_bib0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00007435-198901000-00002","article-title":"Clinical efficacy of new quinolones for therapy of nongonococcal urethritis","volume":"16","author":"Perea","year":"1989","journal-title":"Sex Transm Dis"},{"key":"10.1007\/s10156-010-0192-z_bib0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7883\/yoken.JJID.2004.17","article-title":"Prevalence and treatment of Chlamydia trachomatis, Ureaplasma urealyticum, and Mycoplasma hominis in patients with non-gonococcal urethritis","volume":"57","author":"Kili\u00e7","year":"2004","journal-title":"Jpn J Infect Dis"},{"key":"10.1007\/s10156-010-0192-z_bib0040","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000238750","article-title":"Randomized comparison of ofloxacin and doxycycline for chlamydia and ureaplasma urethritis and cervicitis","volume":"36","author":"Mogabgab","year":"1990","journal-title":"Chemotherapy"},{"key":"10.1007\/s10156-010-0192-z_bib0045","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1128\/AAC.32.9.1336","article-title":"In vitro activity of DR-3355, an optically active ofloxacin","volume":"32","author":"Une","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s10156-010-0192-z_bib0050","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1128\/JCM.40.1.105-110.2002","article-title":"Phylogeny-based rapid identification of Mycoplasma and Ureaplasma from urethritis patients","volume":"40","author":"Yoshida","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1007\/s10156-010-0192-z_bib0055","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10156-008-0643-Y","article-title":"Clinical efficacy of azithromycin for male nongonococcal urethritis","volume":"14","author":"Takahashi","year":"2008","journal-title":"J Infect Chemother"},{"key":"10.1007\/s10156-010-0192-z_bib0060","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00007435-200209000-00001","article-title":"Azithromycin versus doxycycline for genital chlamydial infections. A meta-analysis of randomized clinical trials","volume":"29","author":"Lau","year":"2002","journal-title":"Sex Transm Dis"},{"key":"10.1007\/s10156-010-0192-z_bib0065","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1086\/496983","article-title":"In vitro activity of fluoroquinolones against Mycoplasma genitalium and their bacteriological efficacy for treatment of M. genitalium-positive nongonococcal urethritis in men","volume":"41","author":"Yasuda","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-010-0192-z_bib0070","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1128\/AAC.49.12.4993-4998.2005","article-title":"Antibiotic susceptibility testing of Mycoplasma genitalium by TaqMan 5\u2032 nuclease real-time PCR","volume":"49","author":"Hamasuna","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s10156-010-0192-z_bib0075","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1128\/AAC.00724-09","article-title":"Antimicrobial susceptibility of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR","volume":"53","author":"Hamasuna","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s10156-010-0192-z_bib0080","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S0022-5347(05)65268-8","article-title":"Mycoplasma genitalium: another important pathogen of nongonococcal urethritis","volume":"167","author":"Deguchi","year":"2002","journal-title":"J Urol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X11705013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X11705013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10156-010-0192-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:47:58Z","timestamp":1761158878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X11705013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"alternative-id":["S1341321X11705013"],"URL":"https:\/\/doi.org\/10.1007\/s10156-010-0192-z","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical efficacy of levofloxacin 500\u00a0mg once daily for 7\u00a0days for patients with non-gonococcal urethritis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s10156-010-0192-z","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}